Drug Type Fusion protein |
Synonyms Cethrin, BA-210, VX-210 |
Target |
Action inhibitors |
Mechanism RHO GTPases inhibitors(Rho family GTPases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2/3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute spinal cord injury | Phase 3 | United States | 01 Jul 2016 | |
acute spinal cord injury | Phase 3 | Canada | 01 Jul 2016 | |
Cervical spinal cord injury | Phase 3 | - | 01 Jul 2015 |
Phase 2/3 | 70 | Placebo | hljsjfsrff(abcwgvckgm) = toxwnopypw fgzzwvmczl (hpvfevxeim, 9.48) View more | - | 22 Jan 2020 | ||
Phase 1 | 48 | Cethrin-treated patients | wjwbypsdms(hlgnhbewqt) = there was a trend to improved sensory scores in treated patients with thoracic injury beqsithucj (jfnpefickr ) | - | 01 Nov 2013 | ||
Phase 1 | 48 | krllvngupk(gfvjkonpmh) = ngzyapbipi tihrzxprtp (yholbpudbv ) | - | 01 May 2011 |